Every figure on this page comes from documents Organon & Co. Common Stock filed with the exchange, and each one was checked against the document itself before publication. What could not be verified is not here.
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $1.6 bn | -2.3% | $108 mn | -25.5% | 6.9% |
| Mar 2026 | $1.5 bn | -3.5% | $146 mn | +67.8% | 10.0% |
| Dec 2025 | $1.5 bn | -5.3% | $-205 mn | -288.1% | -13.6% |
| Sep 2025 | $1.6 bn | +1.3% | $160 mn | -55.4% | 10.0% |
| Jun 2025 | $1.6 bn | -0.8% | $145 mn | -25.6% | 9.1% |
| Mar 2025 | $1.5 bn | -6.7% | $87 mn | -56.7% | 5.8% |
Watch it, and each morning it files something you get the checked numbers, the sources, and red-flag alerts when the quiet numbers move — pledges, ratings, resignations. Ask by name any evening and it is read overnight.
Start free — first week on us →Data from documents filed with the exchanges, checked against the documents themselves. This page states facts and is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI and verified against filed documents. Terms, disclosures and grievances